Covered recipient · General Payments record
SELENA N CARMONA
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$788.97
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $497.00 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $137.41 | 1 |
| Astellas Pharma US Inc | $86.25 | 3 |
| PharmaEssentia USA Corporation | $56.92 | 2 |
| SOBI, INC | $55.62 | 2 |
| Celgene Corporation | $38.19 | 2 |
| Janssen Biotech, Inc. | $27.54 | 1 |
| ABBVIE INC. | $27.40 | 1 |
| Lilly USA, LLC | $24.69 | 1 |
| GlaxoSmithKline, LLC. | $22.30 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.40 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106880587 | CMS |
| Astellas Pharma US Inc | $28.55 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139479534 | CMS |
| Astellas Pharma US Inc | $26.31 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139479420 | CMS |
| Astellas Pharma US Inc | $31.39 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139547905 | CMS |
| Celgene Corporation | $17.90 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101196327 | CMS |
| Celgene Corporation | $20.29 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101196329 | CMS |
| GlaxoSmithKline, LLC. | $22.30 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116394196 | CMS |
| Janssen Biotech, Inc. | $27.54 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078725435 | CMS |
| Lilly USA, LLC | $24.69 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135887477 | CMS |
| Novartis Pharmaceuticals Corporation | $20.68 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086777673 | CMS |
| PFIZER INC. | $137.41 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132029425 | CMS |
| PharmaEssentia USA Corporation | $28.59 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137304755 | CMS |
| PharmaEssentia USA Corporation | $28.33 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137304785 | CMS |
| SOBI, INC | $28.85 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141435875 | CMS |
| SOBI, INC | $26.77 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141435877 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.